<html><body><h1 style="font-size:21.0px;">Are acute type A aortic</h1><p style="font-size:9.0px;">Background:  Type  A  aortic  dissections  (TAAD)  are  devastating  aortic</p><h1 style="font-size:21.0px;">dissections atherosclerotic?</h1><p style="font-size:9.0px;">complications. Patients with Marfan syndrome, a bicuspid aortic valve or a</p><h1 style="font-size:10.137423404255319px;">Nimrat Grewal1,2,3*, Onur Dolmaci1,2, Evert Jansen1,</h1><p style="font-size:9.0px;">thoracic aortic aneurysm have an increased risk to develop a TAAD. These</p><h1 style="font-size:10.53125px;">Robert Klautz1,2, Antoine Driessen1, Jan Lindeman4 and</h1><p style="font-size:9.0px;">predisposing conditions are characterized by a histologically thin intimal layer</p><h1 style="font-size:10.289473684210526px;">Robert E. Poelmann5,6</h1><p style="font-size:9.0px;">and hardly any atherosclerosis. Little is known about the susceptibility for</p><h1 style="font-size:13.5px;">1. Introduction</h1><p style="font-size:9.0px;">atherosclerosis in patients with a type A aortic dissection.</p><h1 style="font-size:13.5px;">2. Materials and methods</h1><p style="font-size:9.0px;">Objective:  We  aim  to  systematically  describe  atherosclerotic  lesions  in</p><h1 style="font-size:12.0px;">2.1. Patients and tissue samples</h1><p style="font-size:9.0px;">TAAD patients.</p><h1 style="font-size:12.0px;">2.2. Histological classiﬁcation of the</h1><p style="font-size:9.0px;">Materials  and  methods:  A  total  of  51  patients  with  a  TAAD  (mean  age</p><h1 style="font-size:12.0px;">lesions</h1><p style="font-size:9.0px;">62.5  ±  10.8  years,  49%  females)  and  17  control  patients  (mean  age</p><h1 style="font-size:12.0px;">2.3. Statistical analysis</h1><p style="font-size:9.0px;">63  ±  5.5  years,  53%  females)  were  included  in  this  study.  Cardiovascular</p><h1 style="font-size:13.5px;">3. Results</h1><p style="font-size:9.0px;">risk  factors  were  assessed  clinically.  All  sections  were  stained  with</p><h1 style="font-size:12.0px;">3.1. Patient population</h1><p style="font-size:9.0px;">Movat  pentachrome  and  hematoxylin  eosin.  Plaque  morphology  was</p><h1 style="font-size:12.0px;">3.2. Morphometric measurements</h1><p style="font-size:9.0px;">classiﬁed  according  to  the  modiﬁed  AHA  classiﬁcation  scheme  proposed</p><h1 style="font-size:12.0px;">3.3. Non-progressive intimal lesions in</h1><p style="font-size:9.0px;">by Virmani et al.</p><h1 style="font-size:12.0px;">type A aortic dissection patients</h1><p style="font-size:9.0px;">Results: In the TAAD group thirty-seven percent were overweight (BMI > 25).</p><h1 style="font-size:12.0px;">3.4. Progressive atherosclerotic lesions</h1><p style="font-size:9.0px;">Diabetes and peripheral arterial disease were not present in any of the patients.</p><h1 style="font-size:12.0px;">in type A aortic dissection patients</h1><p style="font-size:9.0px;">Fifty-nine percent of the patients had a history of hypertension. The intima</p><h1 style="font-size:12.0px;">3.5. Atherosclerotic lesions in control</h1><p style="font-size:9.0px;">in TAAD patients was signiﬁcantly thinner as compared to the control group</p><h1 style="font-size:12.0px;">patients and intimal inﬂammation</h1><p style="font-size:9.0px;">(mean thickness 143 ± 126.5 µm versus 193 ± 132 µm, p < 0.023). Seven TAAD</p><h1 style="font-size:13.5px;">4. Discussion</h1><p style="font-size:9.0px;">patients had a normal intima without any form of adaptive or pathological</p><h1 style="font-size:13.5px;">Data availability statement</h1><p style="font-size:9.0px;">thickening.  Twenty-three  TAAD  patients  demonstrated  adaptive  intimal</p><h1 style="font-size:13.5px;">Ethics statement</h1><p style="font-size:9.0px;">thickening. Fourteen had an intimal xanthoma, also known as fatty streaks.</p><h1 style="font-size:13.5px;">Author contributions</h1><p style="font-size:9.0px;">A minority of 7 TAAD patients had progressive atherosclerotic lesions, 4 of</p><h1 style="font-size:13.5px;">Publisher’s note</h1><p style="font-size:9.0px;">which demonstrated pathological intimal thickening, 3 patients showed early</p><h1 style="font-size:13.5px;">Conﬂict of interest</h1><p style="font-size:9.0px;">ﬁbroatheroma, late ﬁbroatheroma and thin cap ﬁbroatheroma. In the control</p><h1 style="font-size:13.5px;">References</h1><p style="font-size:9.0px;">group  the  majority  of  the  patients  exhibited  progressive  atherosclerotic</p><p style="font-size:9.0px;">lesions: three pathologic intimal thickening, two early ﬁbroatheroma, six late</p><p style="font-size:9.0px;">ﬁbroatheroma, one healed rupture and two ﬁbrotic calciﬁed plaque.</p><p style="font-size:9.0px;">Discussion: This study shows that TAAD patients hardly exhibit any form of</p><p style="font-size:9.0px;">progressive atherosclerosis. The majority of TAAD patients showcase non-</p><p style="font-size:9.0px;">progressive intimal lesions, whereas the control group mostly demonstrated</p><p style="font-size:9.0px;">progressive intimal atherosclerotic lesions. Findings are independent of age,</p><p style="font-size:9.0px;">sex, or the presence of (a history of) hypertension.</p><p style="font-size:9.0px;">A type A aortic dissection is a life-threatening condition</p><p style="font-size:9.0px;">caused by a tear in the intimal layer, which allows blood to</p><p style="font-size:9.0px;">surge through the middle layer of the wall, causing the vascular</p><p style="font-size:9.0px;">layers to separate (dissect) from one another. Epidemiologically,</p><p style="font-size:9.0px;">patients with hypertension, connective tissue disorders or a</p><p style="font-size:9.0px;">a thoracic aortic aneurysm or aortic dissection (TAAD) (1,</p><p style="font-size:9.0px;">2).  Traditionally,  cardiovascular  risk  factors  such  as  aging,</p><p style="font-size:9.0px;">dyslipidaemia, smoking, chronic kidney disease, and diabetes</p><p style="font-size:9.0px;">were  related  to  the  occurrence  of  TAADs.  Thoracic  aortic</p><p style="font-size:9.0px;">aneurysms and dissections can, however, develop in the absence</p><p style="font-size:9.0px;">of cardiovascular risk factors and aﬀect young individuals as</p><p style="font-size:9.0px;">a result of genetic disorders (3, 4). The mechanisms initiating</p><p style="font-size:9.0px;">and stimulating the progression of an aortic dissection are still</p><p style="font-size:9.0px;">poorly understood. More recently attention has been drawn</p><p style="font-size:9.0px;">toward the intrinsic pathology of the aortic vessel wall. Bicuspid</p><p style="font-size:9.0px;">aortic valve and Marfan syndrome (MFS) are both associated</p><p style="font-size:9.0px;">with  an  extremely  high  risk  to  develop  a  thoracic  aortic</p><p style="font-size:9.0px;">dissection (5, 6). During the last decade, a number of studies</p><p style="font-size:9.0px;">dealing with the embryonic development of aortopathy in BAV</p><p style="font-size:9.0px;">and MFS have signiﬁcantly improved our knowledge on the</p><p style="font-size:9.0px;">etiology (7, 8). In both conditions an altered neural crest cell and</p><p style="font-size:9.0px;">second heart ﬁeld contribution, separately or in combination,</p><p style="font-size:9.0px;">can account for a maturation defect of the vascular smooth</p><p style="font-size:9.0px;">muscle cells resulting in a structurally diﬀerent aortic root and</p><p style="font-size:9.0px;">ascending aortic wall (8, 9). Besides undiﬀerentiated vascular</p><p style="font-size:9.0px;">smooth muscle cells in the medial layer, signiﬁcant diﬀerences</p><p style="font-size:9.0px;">in the intimal layer have also been noted in BAV and MFS.</p><p style="font-size:9.0px;">The intima has been found signiﬁcantly thinner in the BAV</p><p style="font-size:9.0px;">and MFS patient groups as compared to individuals with a</p><p style="font-size:9.0px;">tricuspid aortic valve (TAV). Vascular smooth muscle cells and</p><p style="font-size:9.0px;">smooth muscle cell-derived cells are a major source of plaque</p><p style="font-size:9.0px;">cells and extracellular matrix at all stages of atherosclerosis</p><p style="font-size:9.0px;">(10).  Clinically,  both  BAV  and  MFS  are  characterized  by</p><p style="font-size:9.0px;">signiﬁcantly  less  atherosclerosis.  Findings  which  are  in  line</p><p style="font-size:9.0px;">with earlier studies highlighting that thoracic aortic aneurysms</p><p style="font-size:9.0px;">are associated with decreased systemic atherosclerosis (11). We</p><p style="font-size:9.0px;">postulate that the combination of a thin intimal layer and a</p><p style="font-size:9.0px;">defect in vascular smooth muscle cell diﬀerentiation might act</p><p style="font-size:9.0px;">protective for the development of atherosclerosis in the vessel</p><p style="font-size:9.0px;">wall. Less is, however, known about the role of atherosclerosis in</p><p style="font-size:9.0px;">patients with a type A aortic dissection. Recently we concluded</p><p style="font-size:9.0px;">that patients with a type A aortic dissection also demonstrate</p><p style="font-size:9.0px;">a signiﬁcantly thinner intimal layer, even in the absence of a</p><p style="font-size:9.0px;">genetic syndrome or a bicuspid aortic valve (12). Considering</p><p style="font-size:9.0px;">the overlap in pathogenetic mechanisms between BAV, MFS,</p><p style="font-size:9.0px;">the presence of atherosclerosis in aortic dissections.</p><p style="font-size:9.0px;">Earlier studies have suggested that patients with a type A</p><p style="font-size:9.0px;">aortic dissection are less prone for atherosclerosis, however,</p><p style="font-size:9.0px;">this has been concluded on basis of imaging studies (11, 13).</p><p style="font-size:9.0px;">The novelty of this paper is that we study atherosclerosis on</p><p style="font-size:9.0px;">tissue level and can detect early stages of atherosclerosis which</p><p style="font-size:9.0px;">would be missed by only studying the images of transesophageal</p><p style="font-size:9.0px;">echocardiography or computed tomography images (11, 14).</p><p style="font-size:9.0px;">The aim of this study is to systematically classify atherosclerotic</p><p style="font-size:9.0px;">lesions in the type A aortic dissection population according</p><p style="font-size:9.0px;">to  the  adapted  AHA  classiﬁcation  as  proposed  by  Virmani</p><p style="font-size:9.0px;">et al. (15).</p><p style="font-size:9.0px;">Fifty-one ascending aortic wall samples were obtained from</p><p style="font-size:9.0px;">the  aortotomy  site  as  residual  aortic  wall  material  during</p><p style="font-size:9.0px;">an  ascending  aortic  replacement  in  patients  with  an  acute</p><p style="font-size:9.0px;">type  A  aortic  dissection  at  the  Leiden  University  Medical</p><p style="font-size:9.0px;">Center, Leiden, Netherlands. Patients with a proven genetic</p><p style="font-size:9.0px;">disorder (e.g., Marfan disease) or a bicuspid aortic valve were</p><p style="font-size:9.0px;">excluded. Seventeen control aortas were obtained during post-</p><p style="font-size:9.0px;">mortem autopsies.</p><p style="font-size:9.0px;">Sample collection was uniform in all patients: ascending</p><p style="font-size:9.0px;">aortic wall specimen were obtained from the aortotomy site. The</p><p style="font-size:9.0px;">aortotomy site is classically in the middle of the ascending aorta,</p><p style="font-size:9.0px;">just beneath the pericardial fold. Circular tissue was obtained</p><p style="font-size:9.0px;">and embedded in paraﬃn. The complete circular ascending</p><p style="font-size:9.0px;">aortic wall was sectioned to avoid sampling of the aortic tissue.</p><p style="font-size:9.0px;">Sample collection and handling was carried out according</p><p style="font-size:9.0px;">to the oﬃcial guidelines of the Medical Ethical Committee of</p><p style="font-size:9.0px;">Leiden University Medical Center and the code of conduct</p><p style="font-size:9.0px;">Autopsy has been performed according to the guidelines of</p><p style="font-size:9.0px;">the  pathology  department.  Tissue  collection  was  performed</p><p style="font-size:9.0px;">according to the regulations and protocols for secondary tissue</p><p style="font-size:9.0px;">use of the department of pathology at the Leiden University</p><p style="font-size:9.0px;">Medical Center. Written informed consent was obtained.</p><p style="font-size:9.0px;">After  excision,  specimens  were  ﬁxed  in  4%  formalin</p><p style="font-size:9.0px;">(24 h), decalciﬁed in a formic acid-formate buﬀer (120 h),</p><p style="font-size:9.0px;">(4  µm)</p><p style="font-size:9.0px;">and  embedded  in  paraﬃn.  Transverse  sections</p><p style="font-size:9.0px;">were  mounted  on  precoated  Starfrost  slides  (Klinipath  BV,</p><p style="font-size:9.0px;">Duiven, Netherlands).</p><p style="font-size:9.0px;">(HE)</p><p style="font-size:9.0px;">(16).  Hematoxylin-eosin</p><p style="font-size:9.0px;">The sectioning and staining protocols have been described</p><p style="font-size:9.0px;">previously</p><p style="font-size:9.0px;">and  Movat</p><p style="font-size:9.0px;">pentachrome  staining  was  performed  for  the  histological</p><p style="font-size:9.0px;">evaluation  of  all  samples  of  each  circular  aortic  specimen.</p><p style="font-size:9.0px;">Sections  were  studied  with  a  Leica  BM5000  microscope</p><p style="font-size:9.0px;">equipped with plan achromatic objectives (Leica Microsystems,</p><p style="font-size:9.0px;">Wetzlar,  Germany).  Each  section  was  individually  classiﬁed</p><p style="font-size:9.0px;">according to the modiﬁed classiﬁcation of the AHA as proposed</p><p style="font-size:9.0px;">by Virmani et al. (15), by two independent observers with no</p><p style="font-size:9.0px;">knowledge of the characteristics of the aortic patch (Table 1).</p><p style="font-size:9.0px;">Across  the  circular  ascending  aortic  wall  tissue  the  plaque</p><p style="font-size:9.0px;">with the most advanced grade of atherosclerosis according to</p><p style="font-size:9.0px;">Virmani et al. (15) called the “dominant plaque” was analyzed</p><p style="font-size:9.0px;">for this study.</p><p style="font-size:9.0px;">Given a role of inﬂammation in atherosclerosis we also</p><p style="font-size:9.0px;">studied the presence of inﬂammatory inﬁltrates in the intimal</p><p style="font-size:9.0px;">layer  of  type  A  aortic  dissection  and  control  patients.  As</p><p style="font-size:9.0px;">inﬂammatory cells are acute phase proteins, an abundance of</p><p style="font-size:9.0px;">these cells is encountered in the dissected medial layer. To study</p><p style="font-size:9.0px;">inﬂammatory cells associated with intimal atherosclerosis, we</p><p style="font-size:9.0px;">studied the inﬂux of inﬂammatory cells in the intimal layer using</p><p style="font-size:9.0px;">the HE and MOVAT pentachrome stained sections, indexed</p><p style="font-size:9.0px;">from zero (no inﬂammatory cells), 1 (a few cells), 2 (groups of</p><p style="font-size:9.0px;">cells) to 3 (large clusters of cells).</p><p style="font-size:9.0px;">All numerical data are presented as the mean ± standard</p><p style="font-size:9.0px;">deviation. Statistical diﬀerences were evaluated with the Mann–</p><p style="font-size:9.0px;">Whitney U test for comparison between the groups. One, two</p><p style="font-size:9.0px;">and three way ANCOVA, binary logistic regression and linear</p><p style="font-size:9.0px;">regression analysis were performed to correct for age, sex and</p><p style="font-size:9.0px;">hypertension. Signiﬁcance was assumed when p < 0.05 with</p><p style="font-size:9.0px;">SPSS  26.0  (SPSS  Inc.,  Chicago,  IL,  USA)  was  used  for  the</p><p style="font-size:9.0px;">statistical analyses.</p><p style="font-size:9.0px;">A total of 51 patients with a type A aortic dissection were</p><p style="font-size:9.0px;">included in the study. The mean age of the study population was</p><p style="font-size:9.0px;">62.5 ± 10.8 years. Females and males were evenly distributed in</p><p style="font-size:9.0px;">the study group (49% females). All patients had a tricuspid aortic</p><p style="font-size:9.0px;">Morphological description</p><p style="font-size:9.0px;">Associated AHA classiﬁcation</p><p style="font-size:9.0px;">N</p><p style="font-size:9.0px;">Mean age</p><p style="font-size:9.0px;">Female (%)</p><p style="font-size:9.0px;">valve and no underlying aortic genetic disease was identiﬁed</p><p style="font-size:9.0px;">after genetic screening by the institutional geneticist.</p><p style="font-size:9.0px;">19 patients (37%) were considered overweight (BMI > 25).</p><p style="font-size:9.0px;">Smoking status was not known for most patients. Diabetes</p><p style="font-size:9.0px;">and peripheral arterial disease were not present in any of the</p><p style="font-size:9.0px;">patients. Chronic obstructive pulmonary disease was seen in</p><p style="font-size:9.0px;">one patient. Fifty-nine percent of the patients had a history</p><p style="font-size:9.0px;">of hypertension (antihypertensive medication or systolic blood</p><p style="font-size:9.0px;">pressure > 140 mmHg and diastolic > 90 mmHg in the period).</p><p style="font-size:9.0px;">group  of  17  patients  were  obtained</p><p style="font-size:9.0px;">the  control  patients  was</p><p style="font-size:9.0px;">post-mortem.  The  mean  age  of</p><p style="font-size:9.0px;">63 ± 5.5 years. Females and males were evenly distributed in the</p><p style="font-size:9.0px;">controls (53% females). All control patients had a non-cardiac</p><p style="font-size:9.0px;">cause of death, had a tricuspid aortic valve and no underlying</p><p style="font-size:9.0px;">genetic disease was known. Data on cardiovascular risk factors</p><p style="font-size:9.0px;">could not be retrieved for all control patients.</p><p style="font-size:9.0px;">control</p><p style="font-size:9.0px;">The</p><p style="font-size:9.0px;">The intima is deﬁned as the area between the inner surface of</p><p style="font-size:9.0px;">the aortic wall, lined by the endothelial cells and the ﬁrst elastic</p><p style="font-size:9.0px;">lamellae of the media (Figure 1). The mean intimal thickness in</p><p style="font-size:9.0px;">all type A dissection patients was 143 ± 126.5 µm. No signiﬁcant</p><p style="font-size:9.0px;">diﬀerence in intimal thickness was observed when corrected for</p><p style="font-size:9.0px;">age and sex or in the presence of (a history of) hypertension</p><p style="font-size:9.0px;">(Age vs intimal thickness p = 0.406; sex vs intimal thickness:</p><p style="font-size:9.0px;">OR 1.00 (95% CI 1.00–1.01), p = 0.669; Hypertension vs intimal</p><p style="font-size:9.0px;">thickness OR 1.00 (95% CI 1.00–1.00), p = 0.860). In control</p><p style="font-size:9.0px;">patients the mean intimal thickness was 193 ± 132 µm, which is</p><p style="font-size:9.0px;">signiﬁcantly thicker as compared to the type A aortic dissection</p><p style="font-size:9.0px;">patients (p < 0.023).</p><p style="font-size:9.0px;">Atherosclerotic lesions in the intima were scored according</p><p style="font-size:9.0px;">to  the  modiﬁed  classiﬁcation  of  the  AHA  as  proposed  by</p><p style="font-size:9.0px;">Virmani  et  al.  (15),  Table  1.  Seven  patients  had  a  normal</p><p style="font-size:9.0px;">intima without any form of adaptive or pathological thickening</p><p style="font-size:9.0px;">(Figure  2A).  The  intimal</p><p style="font-size:9.0px;">layer  had  a  mean  thickness  of</p><p style="font-size:9.0px;">81 ± 62.7 µm in these patients. Mean age in this group was</p><p style="font-size:9.0px;">63.3 ± 9.3 years and 43% was female.</p><p style="font-size:9.0px;">dissection</p><p style="font-size:9.0px;">Twenty-three</p><p style="font-size:9.0px;">type  A  aortic</p><p style="font-size:9.0px;">patients</p><p style="font-size:9.0px;">demonstrated adaptive intimal thickening (Figure 2B). In these</p><p style="font-size:9.0px;">patients  the  intimal  thickening  consisted  mainly  of  smooth</p><p style="font-size:9.0px;">muscle cells with an increase in proteoglycan-rich matrix. Mean</p><p style="font-size:9.0px;">intimal thickness in this group was 103.4 ± 56 µm, and mean</p><p style="font-size:9.0px;">age was 62.1 ± 10 years. Sixty-one percent of the patients with</p><p style="font-size:9.0px;">adaptive intimal thickening were female.</p><p style="font-size:9.0px;">As soon as macrophage-derived foam cells become evident</p><p style="font-size:9.0px;">in the intima the lesions are referred to as intimal xanthoma,</p><p style="font-size:9.0px;">also known as fatty streaks (Figure 2C). These lesions were seen</p><p style="font-size:9.0px;">in 14 patients, with a mean age of 62.6 ± 14.9 years and 14% was</p><p style="font-size:9.0px;">female. Mean thickness of the intima was 151.6 ± 94.4 µm.</p><p style="font-size:9.0px;">A total of seven patients had progressive atherosclerotic</p><p style="font-size:9.0px;">lesions (Figure 3 and Table 1). The mean age of these patients</p><p style="font-size:9.0px;">was 62.7 ± 7.2 years and 86% was female. Four out of these</p><p style="font-size:9.0px;">seven patients demonstrated pathological intimal thickening</p><p style="font-size:9.0px;">with a mean intimal thickness of 244.0 ± 156.2 µm (Figure 3A).</p><p style="font-size:9.0px;">Mean  age  of  the  four  patients  was  64.2  ±  7  years,  all  of</p><p style="font-size:9.0px;">which were female. The remaining three patients showed early</p><p style="font-size:9.0px;">ﬁbroatheroma (Figure 3B), late ﬁbroatheroma (Figure 3C) and</p><p style="font-size:9.0px;">thin cap ﬁbroatheroma (Figure 3D).</p><p style="font-size:9.0px;">The severity of the atherosclerotic lesions was independent</p><p style="font-size:9.0px;">of age, sex, and the cardiovascular risk factor hypertension (age</p><p style="font-size:9.0px;">vs atherosclerosis classiﬁcation p = 0.976; sex vs atherosclerosis</p><p style="font-size:9.0px;">classiﬁcation:  OR  0.99  (95%  CI  0.63–1.56),  p  =  0.960;</p><p style="font-size:9.0px;">hypertension vs atherosclerosis classiﬁcation: OR 1.14 (95% CI</p><p style="font-size:9.0px;">0.72–1.78); p = 0.587).</p><p style="font-size:9.0px;">Non-progressive atherosclerotic lesions (intimal xanthoma)</p><p style="font-size:9.0px;">were  seen  in  only  three  patients  (Table  2).  Patients  from</p><p style="font-size:9.0px;">exhibited  progressive</p><p style="font-size:9.0px;">the</p><p style="font-size:9.0px;">atherosclerotic  lesions.  Three  patients  showed  pathological</p><p style="font-size:9.0px;">control  group  predominantly</p><p style="font-size:9.0px;">intimal thickening (Figure 4A), two had early ﬁbroatheroma</p><p style="font-size:9.0px;">(Figure 4B), six demonstrated late ﬁbroatheroma (Figure 4C),</p><p style="font-size:9.0px;">one had a healed rupture (Figure 4D), and two had a ﬁbrotic</p><p style="font-size:9.0px;">calciﬁed plaque (Figure 4E and Table 2). Sex was randomly</p><p style="font-size:9.0px;">distributed  across  the  non-  and  progressive  atherosclerotic</p><p style="font-size:9.0px;">lesions.</p><p style="font-size:9.0px;">in  the</p><p style="font-size:9.0px;">As inﬂammatory cells are associated with the development</p><p style="font-size:9.0px;">of atherosclerosis, we studied the inﬁltration of inﬂammatory</p><p style="font-size:9.0px;">cells</p><p style="font-size:9.0px;">layer.  The  qualitative  amount  of</p><p style="font-size:9.0px;">inﬂammatory  cells  was  signiﬁcantly  higher  in  the  control</p><p style="font-size:9.0px;">group as compared to the type A aortic dissection patients</p><p style="font-size:9.0px;">(p < 0.0001) (Figures 4F, G).</p><p style="font-size:9.0px;">intimal</p><p style="font-size:9.0px;">In  this</p><p style="font-size:9.0px;">study  we  analyzed  atherosclerotic  lesions</p><p style="font-size:9.0px;">in</p><p style="font-size:9.0px;">type  A  aortic  dissection  patients.  We  found  a  very  low</p><p style="font-size:9.0px;">incidence of progressive atherosclerotic lesions in the study</p><p style="font-size:9.0px;">population. Major cardiovascular risk factors for atherosclerosis</p><p style="font-size:9.0px;">(i.e., age, sex, hypertension, and diabetes mellitus) were not</p><p style="font-size:9.0px;">associated with atherosclerosis. The control group on the other</p><p style="font-size:9.0px;">hand demonstrated predominantly progressive atherosclerotic</p><p style="font-size:9.0px;">lesions. The intimal layer further showed signiﬁcantly more</p><p style="font-size:9.0px;">inﬂux of inﬂammatory cells in the control patients as compared</p><p style="font-size:9.0px;">to the intimal layer in type A aortic dissections, this ﬁnding</p><p style="font-size:9.0px;">is  in  line  with  earlier  suggestions  that  inﬂammation  may</p><p style="font-size:9.0px;">Morphological description</p><p style="font-size:9.0px;">Associated AHA classiﬁcation</p><p style="font-size:9.0px;">Type A dissections group</p><p style="font-size:9.0px;">Control group</p><p style="font-size:9.0px;">N</p><p style="font-size:9.0px;">N</p><p style="font-size:9.0px;">contribute to the development of atherosclerosis. The presence</p><p style="font-size:9.0px;">of inﬂammatory cells in the intimal layer of the ascending aorta</p><p style="font-size:9.0px;">is an interesting ﬁnding and further studies should be performed</p><p style="font-size:9.0px;">to characterize the type of inﬂammatory cells present. Findings</p><p style="font-size:9.0px;">of this study are consistent with previous observations that</p><p style="font-size:9.0px;">conditions predisposing for the development of a type A aortic</p><p style="font-size:9.0px;">dissection, being patients with Marfan syndrome, a bicuspid</p><p style="font-size:9.0px;">aortic valve and a thoracic aortic aneurysm, also associate with a</p><p style="font-size:9.0px;">lower prevalence of atherosclerosis (11, 17).</p><p style="font-size:9.0px;">A  type  A  aortic  dissection  is  a  life-threatening  aortic</p><p style="font-size:9.0px;">complication. Although several risk factors have been described</p><p style="font-size:9.0px;">predisposing  individuals  for  this  lethal  condition,  the  exact</p><p style="font-size:9.0px;">pathogenesis has not yet been identiﬁed (18). Roughly, the</p><p style="font-size:9.0px;">development  of  an  aortic  dissection  requires  three  main</p><p style="font-size:9.0px;">stress,  a</p><p style="font-size:9.0px;">pathological  conditions,  being  mechanical  wall</p><p style="font-size:9.0px;">susceptible  intimal</p><p style="font-size:9.0px;">layer  and  medial  degeneration  (12,  19).</p><p style="font-size:9.0px;">Our previous study had shown that medial pathology in type</p><p style="font-size:9.0px;">A aortic dissections is comparable with thoracic aneurysms</p><p style="font-size:9.0px;">in patients with a tricuspid aortic valve with smooth muscle</p><p style="font-size:9.0px;">cell nuclei loss, mucoid extracellular matrix accumulation and</p><p style="font-size:9.0px;">elastic ﬁber fragmentation and loss (12). The intimal layer was,</p><p style="font-size:9.0px;">however,  signiﬁcantly  thinner  as  compared  to  the  tricuspid</p><p style="font-size:9.0px;">thoracic aortopathy patients, resembling the intima in patients</p><p style="font-size:9.0px;">with Marfan syndrome and a bicuspid aortic valve (20, 21).</p><p style="font-size:9.0px;">As  aortic  dissections  commence  with  a  tear  in  the  intimal</p><p style="font-size:9.0px;">layer, it is particularly interesting to understand whether the</p><p style="font-size:9.0px;">pathology  present  is  comparable  to  degenerative  or  genetic</p><p style="font-size:9.0px;">thoracic aortopathy.</p><p style="font-size:9.0px;">Age is an important factor in the atherosclerotic process</p><p style="font-size:9.0px;">and is related with a signiﬁcant change in the physiological</p><p style="font-size:9.0px;">and pathological properties of the vessel wall (22, 23). Studies</p><p style="font-size:9.0px;">focusing on the natural history of atherosclerosis have shown</p><p style="font-size:9.0px;">that  advanced  atherosclerotic  disease  is  common  in  people</p><p style="font-size:9.0px;">over  45.  In  this  study  we  excluded  patients  with  a  genetic</p><p style="font-size:9.0px;">syndrome  and/or  a  bicuspid  aortic  valve,  and  all  patients</p><p style="font-size:9.0px;">analyzed were aged and presented with so-called degenerative</p><p style="font-size:9.0px;">thoracic aortopathy. In the study population age did not diﬀer</p><p style="font-size:9.0px;">signiﬁcantly between the sub-groups of non-and progressive</p><p style="font-size:9.0px;">intimal lesions as suggested by Virmani et al. (15). Moreover,</p><p style="font-size:9.0px;">86%  of</p><p style="font-size:9.0px;">the  patients  had  no  signs  of  progressive  intimal</p><p style="font-size:9.0px;">atherosclerosis,  with  the  majority  demonstrating  a  normal</p><p style="font-size:9.0px;">aorta or adaptive intimal thickening even at an advanced age.</p><p style="font-size:9.0px;">This is contrast to the control group of comparable age and</p><p style="font-size:9.0px;">gender distribution, which predominantly exhibited progressive</p><p style="font-size:9.0px;">atherosclerotic lesions. A comparative study performed by Heng</p><p style="font-size:9.0px;">et al. used heart transplant recipients as control aortic tissue</p><p style="font-size:9.0px;">and found no atherosclerosis in this group (24). These patients</p><p style="font-size:9.0px;">were, however, almost 5–6 years younger than the patients</p><p style="font-size:9.0px;">studied in our paper. This could explain the diﬀerence in our</p><p style="font-size:9.0px;">ﬁndings. Future studies should pay additional attention to the</p><p style="font-size:9.0px;">cardiovascular risk factors in the control group. Our data further</p><p style="font-size:9.0px;">suggests that in the type A dissection population progressive</p><p style="font-size:9.0px;">aortic atherosclerosis occurs more often in women than in</p><p style="font-size:9.0px;">men, an observation that concurs with clinical observations</p><p style="font-size:9.0px;">showing that peripheral artery disease develops earlier and at a</p><p style="font-size:9.0px;">relatively high rate in women (25, 26). In the control group a</p><p style="font-size:9.0px;">female predominance was not observed in the progressive aortic</p><p style="font-size:9.0px;">atherosclerotic lesions.</p><p style="font-size:9.0px;">Earlier</p><p style="font-size:9.0px;">studies  have  suggested  that  patients  with  a</p><p style="font-size:9.0px;">thoracic  aortic  aneurysm  or  aortic  dissection  demonstrate</p><p style="font-size:9.0px;">less atherosclerotic lesions (11, 13, 17, 27). These studies used</p><p style="font-size:9.0px;">imaging  modalities  such  as  TEE  or  CT  scanning  to  score</p><p style="font-size:9.0px;">atherosclerotic  lesions  across  the  aorta  (28).  In  this  paper</p><p style="font-size:9.0px;">we  studied  the  histological  classiﬁcation  of  atherosclerosis</p><p style="font-size:9.0px;">on aortic tissue level to be able to also detect early stages of</p><p style="font-size:9.0px;">atherosclerosis which would be missed by only studying the</p><p style="font-size:9.0px;">transesophageal  echocardiography  or  computed</p><p style="font-size:9.0px;">images  of</p><p style="font-size:9.0px;">tomography images (11, 14). As more than 90% of the type A</p><p style="font-size:9.0px;">aortic dissections commence within the ﬁrst few centimeters of</p><p style="font-size:9.0px;">the ascending aortic wall, and the aortic root and arch are not</p><p style="font-size:9.0px;">always involved, we uniformly studied the ascending aorta in all</p><p style="font-size:9.0px;">patients. In our earlier studies we have paid particular attention</p><p style="font-size:9.0px;">to the role of shear stress on the histopathology of the aortic</p><p style="font-size:9.0px;">wall in patients with a bicuspid and tricuspid aortic valve, with</p><p style="font-size:9.0px;">and without dilatation and found no diﬀerence in the amount</p><p style="font-size:9.0px;">of atherosclerosis (29). With magnetic resonance imaging the</p><p style="font-size:9.0px;">area with maximum shear stress in the ascending aortic wall</p><p style="font-size:9.0px;">was compared to the opposite site (non-jet side). Diﬀerences</p><p style="font-size:9.0px;">were appreciated in the intimal thickness, but without features</p><p style="font-size:9.0px;">of atherosclerosis (29).</p><p style="font-size:9.0px;">We recognize that atherosclerosis is a pathological entity,</p><p style="font-size:9.0px;">even though our study has dealt with many limitations by</p><p style="font-size:9.0px;">performing histopathological analysis and avoiding sampling</p><p style="font-size:9.0px;">errors, the lesions represent a very short segment of ascending</p><p style="font-size:9.0px;">aorta,  and  areas  of  atheroma  may  be  missed.  Staining  for</p><p style="font-size:9.0px;">smooth  muscle  cells  and  immune  cell  markers  should  be</p><p style="font-size:9.0px;">considered  in  future  studies  to  conﬁrm  our  ﬁndings.  Our</p><p style="font-size:9.0px;">study is further limited by the low number of control patients</p><p style="font-size:9.0px;">versus the dissected specimen. Even though genetic screening is</p><p style="font-size:9.0px;">performed in the patients to exclude an aortic genetic disease,</p><p style="font-size:9.0px;">unknown genetic mutations associated with sporadic type A</p><p style="font-size:9.0px;">dissections can be missed.</p><p style="font-size:9.0px;">Our  ﬁndings  emphasize  that  a  type  A  aortic  dissection</p><p style="font-size:9.0px;">occurs in the absence of clinical cardiovascular risk factors</p><p style="font-size:9.0px;">as diabetes, dyslipidaemia and peripheral arterial and despite</p><p style="font-size:9.0px;">aging most patients have minimal atherosclerotic lesions. We</p><p style="font-size:9.0px;">postulate that a thin intimal layer could increase susceptibility</p><p style="font-size:9.0px;">for a future aortic dissection, but at the same time acts protective</p><p style="font-size:9.0px;">for systemic atherosclerosis.</p><p style="font-size:9.0px;">The raw data supporting the conclusions of this article will</p><p style="font-size:9.0px;">be made available by the authors, without undue reservation.</p><p style="font-size:9.0px;">The studies involving human participants were reviewed</p><p style="font-size:9.0px;">and approved by the Medical Ethical Committee of Leiden</p><p style="font-size:9.0px;">University Medical Center. The patients/participants provided</p><p style="font-size:9.0px;">their written informed consent to participate in this study.</p><p style="font-size:9.0px;">NG conceived and designed the experiments, performed</p><p style="font-size:9.0px;">the experiments, analyzed and interpreted the data, contributed</p><p style="font-size:9.0px;">reagents and materials, and wrote the manuscript. OD, EJ, and</p><p style="font-size:9.0px;">AD  wrote  the  manuscript.  RK  conceived  and  designed  the</p><p style="font-size:9.0px;">experiments, contributed reagents and materials, and wrote the</p><p style="font-size:9.0px;">manuscript. JL contributed reagents and materials and wrote</p><p style="font-size:9.0px;">the manuscript. RP conceived and designed the experiments,</p><p style="font-size:9.0px;">analyzed and interpreted the data, contributed reagents and</p><p style="font-size:9.0px;">materials, and wrote the manuscript. All authors contributed to</p><p style="font-size:9.0px;">the article and approved the submitted version.</p><p style="font-size:9.0px;">The reviewer M-JG declared a shared aﬃliation with the</p><p style="font-size:9.0px;">authors  NG,  OD,  JL,  and  RP  to  the  handling  editor  at</p><p style="font-size:9.0px;">the time of review.</p><p style="font-size:9.0px;">The authors declare that the research was conducted in the</p><p style="font-size:9.0px;">absence of any commercial or ﬁnancial relationships that could</p><p style="font-size:9.0px;">be construed as a potential conﬂict of interest.</p><p style="font-size:9.0px;">All claims expressed in this article are solely those of the</p><p style="font-size:9.0px;">authors and do not necessarily represent those of their aﬃliated</p><p style="font-size:9.0px;">organizations, or those of the publisher, the editors and the</p><p style="font-size:9.0px;">reviewers. Any product that may be evaluated in this article, or</p><p style="font-size:9.0px;">claim that may be made by its manufacturer, is not guaranteed</p><p style="font-size:9.0px;">or endorsed by the publisher.</p></body></html>